Life Sciences and Pharma IP 2026

Definitive global law guides offering comparative analysis from top-ranked lawyers


INTRODUCTION
5

Contributed by Daniel Lim, Steven Baldwin and Jin Ooi, Kirkland & Ellis International LLP
5

AUSTRALIA
10

Trends and Developments
10

Contributed by Maddocks
10

BRAZIL
17

Law and Practice
17

Contributed by Licks Attorneys
17

Trends and Developments
33

Contributed by Licks Attorneys
33

CHINA
39

Law and Practice
39

Contributed by LeanWill Law Firm
39

GERMANY
58

Law and Practice
58

Contributed by HOFFMANN EITLE
58

Trends and Developments
75

Contributed by HOFFMANN EITLE
75

INDIA
82

Trends and Developments
82

Contributed by Anand and Anand
82

ISRAEL
90

Law and Practice
90

Contributed by Gilat, Bareket & Co, Reinhold Cohn Group
90

JAPAN
109

Law and Practice
109

Contributed by Ohno & Partners
109

Trends and Developments
120

Contributed by Nagashima Ohno & Tsunematsu
120

MEXICO
127

Law and Practice
127

Contributed by Arochi & Lindner
127

NORWAY
146

Law and Practice
146

Contributed by Wikborg Rein Advokatfirma AS
146

PHILIPPINES
158

Law and Practice
158

Contributed by Villaraza & Angangco
158

POLAND
175

Law and Practice
175

Contributed by A&O Shearman
175

SAUDI ARABIA
194

Law and Practice
194

Contributed by Mohammed AlDhabaan & Partners Eversheds Sutherland
194

Trends and Developments
210

Contributed by Mohammed AlDhabaan & Partners Eversheds Sutherland
210

SINGAPORE
215

Law and Practice
215

Contributed by Drew & Napier LLC
215

SOUTH KOREA
235

Law and Practice
235

Contributed by Bae, Kim & Lee LLC
235

Trends and Developments
247

Contributed by Bae, Kim & Lee LLC
247

USA
254

Law and Practice
254

Contributed by Gemini Law LLP
254

Trends and Developments
271

Contributed by Tensegrity Law Group LLP
271

Powered by